Security Name: 8.90% Astec Lifesciences Limited 25 Mar 2027
ISIN:
INE563J08023
Taxable
Tax Category
25 Mar, 2027
Maturity Date
(1 Yr 7 Mo 20 D to mature)
Yearly
Interest Payment Frequency
Yes
NRI Eligibility
27 Mar, 2025
Allotment Date
NA
Put Date
27 Mar, 2026
Next Interest Payment Date
15 days
Shut Period
Both
Active on NSDL/CDSL
Non-Guaranteed
Type of Guarantee
No
Perpetual
Private Placement
Mode of Issue
Listed
Listing Details
Non Public Sector Undertaking
Type of Issuer
Quote Not Available
Dirty Price
8.9%
Coupon
Fixed Interest
Coupon Basis
Quote Not Available
Current Yield
12 Mar, 2026
Record Date
YOUR EARNING
Your Investment
Final Payout
₹0
Error Generating Cashflow 😥. We are looking into this.
*All Interest Payments will be subject to TDS (Not Applicable on Government Securities and Tax Free Bonds)
YOUR RISK
Repayment Priority
Higher the level, higher the priority of investment repayment on default
Security with Collateral?
An investment secured with collateral helps
ISSUER
Astec Lifesciences Limited
Astec is involved in manufacturing and sale of intermediates, active ingredients and formulations, with a focus on the agro-chemicals sector. The company has five manufacturing plants in Mahad (Maharashtra) and two R&D centres in Dombivali and Rabale (Maharashtra). While the Dombivali unit was acquired by the company in 1994, one of the three units of Mahad was procured from Behram Chemicals Private Limited in 2002. In FY2012, Astec forayed into the contract manufacturing segment by securing contracts from reputed global players. The company also started manufacturing herbicides from August 2021 onwards.
The ratio for FY24 is negative<strong>( -1533.82)</strong> due to incurred loss for the year due to challenging market conditions and it was 3.82x in FY23 indicating increase in debt level.
Debt/EBITDA
The ratio in FY24 is -1.45x and it was 2.68x in FY23, indicating decline in the debt servicing ability of the issuer due to increase in the interest expenses which led to increase in the finance cost.
Interest coverage ratio
Recent News
Astec LifeSciences Allots Rs. 49 Crore in Debentures to Boost Financial Position
Apr 01, 2025 | Astec Lifesciences Limited
Related Videos
STEPS TO BUY THIS BOND
Information required for KYC
PAN Card
Bank Account Proof
Aadhaar Card
Demat Account Proof
How to exit the investment?
To know more about the Bond and the issuer, download the Information Memorandum.
To read about the reasons for the ratings assigned to the Bond, download the Rating Rationale.
Clean Price
Yield (YTM)
Principal Amount
Accrued Interest from
Select the number of units below
BOND VALUE DETAILS
Face Value
Market Value
Stamp Duty
Select a Settlement Date:
Total Investment
| Cashflow for INE563J08023 |
|---|
| Disclaimer: The actual dates and interest amounts can vary depending on Bank closures, holidays etc. Tax Deducted at Source (TDS) is applicable on interest receivable based on relevant tax regulations. You can avail TDS credit while filing your Income Tax Return (ITR). |
|---|
| Security Name |
|---|
| 8.90% Astec Lifesciences Limited 25 Mar 2027 |
| Credit Rating |
|---|
| AA - by ICRA |
| Coupon Frequency |
|---|
| Yearly |
| Face Value |
|---|
| ₹1,00,000 |
| Coupon |
|---|
| 8.900000% |
| YTM or YTC |
|---|
| YTM |
| Maturity Date |
|---|
| 25/03/2027 |
| Security |
|---|
| Unsecured |
| No. of Bonds |
|---|
| 1 |
| Settlement Date |
|---|
| Principal Amount |
|---|
| ₹NaN |
| Accrued Interest |
|---|
| ₹0 |
| Stamp Duty |
|---|
| ₹0 |
| Total Amount Payable |
|---|
| ₹NaN |
| Price |
|---|
| ₹NaN |
| Yield |
|---|
| % |
| Year | Payment Date | Amount | Amount after TDS | Payout Type |
|---|
Quote Not Available for purchase
Disclaimer: Investments in Debt Securities/ Municipal Debt Securities/ Securitised Debt Instruments are subject to risks including delay and/ or default in payment. Read all the Offer Related documents carefully.
Source: Issuer website, Rating Rationale, Issuer Annual Report, Information Memorandum and News from Google.
